Search results
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
The Motley Fool via AOL· 34 minutes agoIn the future, the company hopes to pick up an indication for more severe forms of fibrosis as well as cirrhosis, and it's currently pursuing clinical trials on that front ...
Edible Carbon Beads Can Reduce Cirrhosis Liver Disease By Restoring Gut Microbiome
GoodNewsNetwork· 23 hours agoInnovative carbon beads, invented by researchers at University College London, reduce bad bacteria...
These Are The 5 Biggest Early Warning Signs Of Liver Damage
BuzzFeed via Yahoo News· 16 hours agoThis is particularly true when you’re experiencing cirrhosis, which is the scarring of the liver. ...
FMT Could Prevent Hepatic Encephalopathy in Cirrhosis
Medscape· 4 days agoA phase 2 trial of fecal microbiota transplantation to prevent hepatic encephalopathy in cirrhosis...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 1 hour agoSZN-043 is a novel biotherapeutic shown to potentiate Wnt signaling and induce proliferation of hepatocytes in preclinical models Treatment with SZN-043 in the Phase 1a trial was safe and well tolerated in healthy volunteers and patients with
AKERO THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC...
WCBD-TV Charleston· 2 days agoKahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C....
Viking Therapeutics Stock Falls After Drug Study Report
Investor's Business Daily· 6 days agoThe company tested its drug, dubbed VK2809, in patients with nonalcoholic steatohepatitis, or NASH....
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel...
Morningstar· 5 days agoNEW YORK, June 5, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Akero Therapeutics, Inc. (NASDAQ: AKRO) between September 13, 2022 and October 9, 2023
She's been waiting for a liver donation for over a year: 'I know God has a plan for me, but its...
CBS 6 Richmond· 3 days agoMother and wife Tina Doane was diagnosed with Stage 4 cirrhosis of the liver and given two years to live if she didn't receive a liver transplant. "Every day that I have a ...
Gilead's Seladelpar Demonstrated a Sustained and Consistent Long-Term Efficacy and Safety Profile in...
Benzinga· 5 days agoGilead Sciences, Inc. GILD, following the recent acquisition of CymaBay Therapeutics, Inc., today announced two-year interim results from the ongoing ASSURE study of investigational seladelpar ...